Recent syntheses of PI3K/Akt/mTOR signaling pathway inhibitors.
about
Molecular classification of gastric cancer: Towards a pathway-driven targeted therapyRecent development of ATP-competitive small molecule phosphatidylinostitol-3-kinase inhibitors as anticancer agentsPredicting mTOR inhibitors with a classifier using recursive partitioning and Naïve Bayesian approachesPemetrexed induces S-phase arrest and apoptosis via a deregulated activation of Akt signaling pathway.Loss of 4E-BP1 function induces EMT and promotes cancer cell migration and invasion via cap-dependent translational activation of snail.Nanoparticle delivery of chemosensitizers improve chemotherapy efficacy without incurring additional toxicity.β-hydroxyisovaleryl-shikonin induces human cervical cancer cell apoptosis via PI3K/AKT/mTOR signalingDiscovering new mTOR inhibitors for cancer treatment through virtual screening methods and in vitro assays.Quercetin Inhibits Fibroblast Activation and Kidney Fibrosis Involving the Suppression of Mammalian Target of Rapamycin and β-catenin Signaling.Quinazoline derivatives as anticancer drugs: a patent review (2011 - present).Synthesis of thiophene and N-substituted thieno[3,2-d] pyrimidine derivatives as potent antitumor and antibacterial agents.The collective nuclear migration of p53 and phosphorylated S473 of Akt during ellipticine-mediated apoptosis in human lung epithelial cancer cells.The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling.Rhodium-Catalyzed Asymmetric N-H Functionalization of Quinazolinones with Allenes and Allylic Carbonates: The First Enantioselective Formal Total Synthesis of (-)-Chaetominine.Proposed Molecular and miRNA Classification of Gastric Cancer.
P2860
Q26798420-65407462-723F-4A33-8EA7-75CFEF98C389Q28067417-962AED9E-3C58-49C9-A8F2-C7DA0ECFAA94Q28538732-24585C1E-7A7E-4B85-B6C2-2911E0AA7418Q33646091-A03EC0E8-3E23-4F58-B42F-AC7D94201BD1Q34227565-FC05B3B3-A6E3-4172-8F3F-3EA46DD0BB90Q35534276-733D2B95-07C1-45EC-89BA-38BA0FD2D90BQ36334776-2B25B738-23B6-42C1-91F1-3F752EA64128Q36432654-80CCC029-0887-4A17-89BD-12E8C142C7E6Q36774306-7C26D1C3-44A0-4A3E-8147-D13A36EEFF32Q38440766-D5A6E1FC-5028-4441-B8F6-0FBE85DE9EECQ38599885-6831B482-64A7-4BBB-B06D-35A568E5F49BQ38870539-22A67883-3168-46ED-90CD-BEC618B9750CQ40900704-151E9525-DD04-45E3-811A-15F97EA74158Q47379124-6F84AE40-7912-460E-A2C9-F3A89FD3CD01Q55603677-E707CD6E-78B6-420A-A638-A0A7E5A50A26
P2860
Recent syntheses of PI3K/Akt/mTOR signaling pathway inhibitors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Recent syntheses of PI3K/Akt/mTOR signaling pathway inhibitors.
@en
Recent syntheses of PI3K/Akt/mTOR signaling pathway inhibitors.
@nl
type
label
Recent syntheses of PI3K/Akt/mTOR signaling pathway inhibitors.
@en
Recent syntheses of PI3K/Akt/mTOR signaling pathway inhibitors.
@nl
prefLabel
Recent syntheses of PI3K/Akt/mTOR signaling pathway inhibitors.
@en
Recent syntheses of PI3K/Akt/mTOR signaling pathway inhibitors.
@nl
P2860
P1476
Recent syntheses of PI3K/Akt/mTOR signaling pathway inhibitors.
@en
P2093
George Kulik
Mark E Welker
P2860
P304
P356
10.1016/J.BMC.2013.04.083
P407
P577
2013-05-09T00:00:00Z